Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.
AIMS--To identify the relative contribution of plasminogen activators, particularly tissue plasminogen activator (t-PA) and specific plasminogen activator inhibitors (PAI-1, PAI-2), to the fibrinolytic changes associated with various types of liver disease or severe chemical and physical damage to t...
保存先:
| 出版年: | J Clin Pathol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
1994
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC501897/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8163691/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jcp.47.3.214 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|